OrthoPediatrics said yesterday it launched its pediatric-specific wrist fusion plate system as part of its PediFrag franchise.
The wrist fusion plate system includes plates in two implant lengths to accomodate patients with and without proximal row carpectomies and features low-profile stainless steel plates to minimize plate prominence and reduce soft-tissue irritation, the Warsaw, Ind.-based company said.
“When pediatric wrist deformities are too severe, ease of personal care, skin hygiene, hand function, and appearance can be adversely affected. For some neuromuscular patients, daily tasks like getting dressed can be difficult or even painful. Surgical intervention can improve the quality of life for many of these children. That’s why OrthoPediatrics designed the first ever pediatric specific plates for wrist fusion. This expanded offering provides our surgical partners a full suite of tools to treat children with orthopedic conditions,” trauma & deformity correction VP Joe Hauser said in an SEC filing.
The newly launched system was developed in collaboration with Australia’s Sydney Children’s Hospital Network with support from an Accelerating Commercialization Grant from the Australian government, the company said.
“We are excited to introduce a new offering to the pediatric orthopedic market. In collaboration with our partners at Sydney Children’s Hospital, we couldn’t be prouder of the Wrist Fusion Plate System that we created together. It’s great to work with a team whose commitment to helping kids mirrors our own,” exec VP David Bailey said in a prepared statement.
In mid-October, OrthoPediatrics priced its initial public offering at $13 per share, meaning the 4-million-share flotation pulled in $52 million for its line of surgical systems for children.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.